JPRN-UMIN000043942已完成未知
Explore research for osimertinib sensitivity in EGFR mutated non-small cell lung cancer; prospective observation study - Explore research for osimertinib sensitivity in EGFR mutated non-small cell lung cancer; prospective observation study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients judged as inappropriate by the physician in charge
研究者
相似试验
进行中（未招募）
1 期
Exploring the theragnostic value of osimertinib in EGFR-mutated lung cancer (THEROS) - A multicentric phase II study in patients with TKI-resistant EGFR-mutated lung cancer exhibiting early metabolic response to osimertinibon-small-cell lung cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-005121-21-DEniversitätsklinikum Essen20
招募中
4 期
Efficacy study of osimertinib in treatment-naïve patients with EGFR mutant NSCLC according to TP53 mutational status (TEMPLE-2)2024-517424-18-00Fondazione Policlinico Universitario Agostino Gemelli IRCCS54
招募中
不适用
A prospective observational study of osimertinib as predictive marker against patients with EGFR mutation positive NSCLC.ung CancerJPRN-UMIN000040432Gunma University50
未知
不适用
A prospective observational study of osimertinib as predictive marker against patients with EGFR T790M-positive NSCLC.ung CancerJPRN-UMIN000027233Gunma University45
尚未招募
2 期
A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical SurgeryLung NeoplasmsLung Cancer, Nonsmall CellNCT06530719Jin Ying54